Mr. Salhi serves as the Head of Biometrics at Ankyra Therapeutics, where he leads the corporate data strategy and oversees statistical methodologies, clinical data analysis, and data management activities across the organization.
He brings over 25 years of extensive experience in the biopharmaceutical industry, spanning early to late-stage clinical development. Prior to joining Ankyra, Mr. Salhi was Vice President of Biostatistics, Statistical Programming, and Modeling & Simulation at Sage Therapeutics. He has also held executive leadership roles in biometrics at Ichnos Sciences, Glenmark Pharmaceuticals, Pierre Fabre, and CAC, contributing to a broad range of therapeutic areas and global development programs.
Mr. Salhi holds both a PhD and an MS in Biomathematics and Biostatistics from the University of Paris Denis Diderot in France.